Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-158,418
Closed -$13.1M 358
2016
Q4
$13.1M Sell
158,418
-346,903
-69% -$24.5M 0.21% 162
2016
Q3
$32.8M Sell
505,321
-2,089
-0.4% -$132K 0.54% 58
2016
Q2
$30.9M Sell
507,410
-5,281
-1% -$309K 0.53% 63
2016
Q1
$29.6M Sell
512,691
-6,554
-1% -$323K 0.52% 61
2015
Q4
$25.8M Sell
519,245
-172,174
-25% -$8.62M 0.48% 67
2015
Q3
$33M Sell
691,419
-84,179
-11% -$4.77M 0.55% 58
2015
Q2
$48.3M Sell
775,598
-99,709
-11% -$6.34M 0.74% 34
2015
Q1
$57.8M Sell
875,307
-23,175
-3% -$1.5M 0.86% 24
2014
Q4
$59.9M Sell
898,482
-65,957
-7% -$4.28M 0.89% 21
2014
Q3
$60.8M Sell
964,439
-37,141
-4% -$2.3M 0.94% 16
2014
Q2
$61.9M Buy
1,001,580
+14,486
+1% +$837K 0.9% 21
2014
Q1
$56.6M Sell
987,094
-9,460
-0.9% -$547K 0.84% 30
2013
Q4
$64.1M Buy
996,554
+40,009
+4% +$2.37M 0.94% 18
2013
Q3
$53.1M Sell
956,545
-12,961
-1% -$715K 0.81% 28
2013
Q2
$50.6M Buy
+969,506
New +$51M 0.82% 29

Boston Trust Walden's CLC Position: Q1 2017 in Review

Boston Trust Walden sold out of Clarcor (CLC) in Q1 2017, closing a stake of 158,418 shares — an estimated $13.1M sold.

Boston Trust Walden first reported a position in CLC in Q2 2013 and held it in 15 quarters. The position peaked at $64.1M in Q4 2013. 0 funds tracked by Wall St. Rank hold CLC as of Q1 2017.

  • Boston Trust Walden reported no remaining Clarcor position as of Q1 2017 after selling out during the quarter.
  • Boston Trust Walden sold 158,418 Clarcor shares in Q1 2017, an estimated $13.1M.
  • Boston Trust Walden first reported a position in Clarcor in Q2 2013 and held it in 15 quarters.
  • Boston Trust Walden's Clarcor position peaked at $64.1M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Clarcor as of Q1 2017.

Based on Boston Trust Walden's 13F filing for Q1 2017, filed 24 Apr 2017.